Groups and Owl Labs improve engagement and remove barriers for in-person and virtual care. BURLINGTON, Mass.–(BUSINESS WIRE)–Groups Recover Together, the nationwide leader in value-based care for opioid addiction treatment, has announced it is now utilizing Owl Labs’ devices to outfit all group therapy rooms across the country with Owl’s AI-enabled, 360-degree meeting technology. COVID shuttered … [Read more…]

Chronic Disease Community Feels Left Behind as Attitudes About the Pandemic Shift UPPER NYACK, N.Y.–(BUSINESS WIRE)–#chronicdisease–Ahead of the holiday season, the Global Healthy Living Foundation polled members (n=802) of their COVID-19 Patient Support Program to understand how the evolving COVID-19 pandemic will impact plans among the chronic disease community to celebrate the holidays with family … [Read more…]

The latest offering from the brand is the first maximum strength cough suppressant and expectorant that replaces the artificial inactive ingredients used by category leaders with clean alternatives ATLANTA–(BUSINESS WIRE)–With the prediction of an early and aggressive 2022 flu season ahead, Genexa—the first clean medicine company to remove all artificial inactive ingredients from its medicines—announced … [Read more…]

– Data supporting high expression of activation and tumor targeting markers of NK cells mass cultured without feeder cells – Proved the excellent anti-tumor efficacy in various solid tumor-bearing animal model – Submitted an IND for phase 1 trial for T.O.P. NK to MFDS last September SEONGNAM, South Korea–(BUSINESS WIRE)–#CAR_NK—GICELL announced the data from the … [Read more…]

Segment’s market share leading, HIPAA-eligible customer data platform enables healthcare organizations to move from transactional to relationship based care that can improve patient engagement and health outcomes SAN FRANCISCO–(BUSINESS WIRE)–Twilio (NYSE: TWLO) (LTSE: TWLO), the customer engagement platform that drives real-time, personalized experiences for today’s leading brands, today announced the general availability of Twilio Segment … [Read more…]

SEOUL, South Korea–(BUSINESS WIRE)–#CRADA—TMD LAB (CEO Hak-Joon Sung) and the National Institute of Standards and Technology (NIST) under the U.S. Department of Commerce are starting joint research on the properties of SMP materials. TMD LAB received a Cooperative Research and Development Agreement (CRADA) proposal from the NIST and signed the agreement on October 11 2022. … [Read more…]

– Study-entry data confirm deficiency in infant microbiomes compared to published literature – – The study, the largest of its kind, has enrolled 680 infants across the U.S., ahead of both schedule and budget due to an enthusiastic response from social media – – My Baby Biome is an observational study to determine gut biomarkers … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that members of the management team will participate in analyst-led fireside chats at the following investor conferences: Guggenheim’s 4th Annual Immunology and Neurology Day Date: Tuesday, November 15, 2022 … [Read more…]

Collaboration will integrate data into hospital patient workflows, supporting remote chronic care and population health management PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a new collaboration with HealthSnap, a leading full-service Virtual Care Management Platform for chronic disease management. The collaboration will enable more … [Read more…]

REMOTE-FIRST COMPANY/NASHVILLE–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative cloud-based healthcare technology solutions, today announced that management will participate in the Stephens Annual Investment Conference with a fireside chat scheduled to begin Tuesday, Nov. 15 at 3 p.m. Eastern Time. A recording of the event will be available at investor.nextgen.com and will … [Read more…]